Evans Hugh M
Transaction: 03/18/2026
OTHER
Change
0
Price
Not reported
Filing
04/27/2026
Type
OTHER
CollPlant Biotechnologies Ltd.
CLGN • Biotechnology
$3.55
— 0.00 (0.00%)
EarningsLatest report: Mar 31, 2026
WEAK PROFILEWeakConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$48.80M
Growth
—
Cash Flow
1/5
Trend
Volatile
Evidence
Manageable debt level · 0.47Healthy liquidity · 2.53Negative growth trendWeak profitability
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: May 29, 2026, 12:00 AM UTCLast profile update: Sep 2, 2026, 12:17 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$3.55
Change0.00%
Shares Out13.75M
Market Cap$48.80M
Enterprise Value$44.54M
52W Range0.26 - 3.18
Beta0.68
P/E-3.72
P/S125.46
P/B9.99
P/FCF-4.21
EV/Sales114.50
Price$3.55
Change0.00%
Shares Out13.75M
Market Cap$48.80M
Enterprise Value$44.54M
52W Range0.26 - 3.18
Beta0.68
P/E-3.72
P/S125.46
P/B9.99
P/FCF-4.21
EV/Sales114.50
EV/EBITDA-3.70
EV/FCF-3.84
Earnings Yield-26.91%
FCF Yield-23.77%
Dividend Yield0.00%
Gross Margin26.32%
Oper. Margin-4.84%
Profit Margin-4.85%
Debt/Eq0.47
Current Ratio2.53
Quick Ratio2.31
Target$12.50
Target Upside252.11%
Target Median$12.50
Target Range11.00 - 14.00
Volume6.84M
Avg Volume161.42K
EPS Surprise0.01
Investment DNA
How strong this company looks for long-term investors
38
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
74/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
62/100
Why this score▼
Manageable debt level · 0.47Healthy liquidity · 2.53Negative growth trendWeak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 5 analyst votes · 2026-09-05
90/100
Bullish
Bullish
4
Hold
1
Bearish
0
Price Target
2026-09-02
Low
$11.00
Mean
$12.50
Median
$12.50
High
$14.00
Insider Transactions
Recent executive and insider activity
Evans Hugh M
Transaction: 03/18/2026
OTHER
Change
0
Price
Not reported
Filing
04/27/2026
Type
OTHER
Evans Hugh M
Transaction: 05/02/2023
OTHER
Change
+24,000
Price
$6.39
Filing
04/27/2026
Type
OTHER
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Evans Hugh M | OTHER | 0 | Not reported | 03/18/2026 | 04/27/2026 |
| Evans Hugh M | OTHER | 0 | Not reported | 03/18/2026 | 04/27/2026 |
| Evans Hugh M | OTHER | +24,000 | $6.39 | 05/02/2023 | 04/27/2026 |
| Tal Yehiel | OTHER | 0 | Not reported | 03/19/2026 | 03/19/2026 |
| Tal Yehiel | OTHER | 0 | Not reported | 03/19/2026 | 03/19/2026 |
| Tal Yehiel | OTHER | +100,000 | $6.39 | 05/02/2023 | 03/19/2026 |
| Tal Yehiel | OTHER | +37,800 | $4.02 | 05/18/2020 | 03/19/2026 |
| Rotem Eran | OTHER | 0 | Not reported | 03/18/2026 | 03/18/2026 |
| Fahimipoor Oren | OTHER | 0 | Not reported | 03/18/2026 | 03/18/2026 |
| Bensimon Philippe | OTHER | 0 | Not reported | 03/18/2026 | 03/18/2026 |
| Bensimon Philippe | OTHER | 0 | Not reported | 03/18/2026 | 03/18/2026 |
| Seror Jasmine | OTHER | 0 | Not reported | 03/18/2026 | 03/18/2026 |
| Abelis Bar Berta | OTHER | 0 | Not reported | 03/18/2026 | 03/18/2026 |
| Bagley Bowman | OTHER | 0 | Not reported | 03/18/2026 | 03/18/2026 |
| Havron Avraham | OTHER | 0 | Not reported | 03/18/2026 | 03/18/2026 |
| Penn Elan | OTHER | 0 | Not reported | 03/18/2026 | 03/18/2026 |
| Lask Alisa | OTHER | 0 | Not reported | 03/18/2026 | 03/18/2026 |
| Fahimipoor Oren | OTHER | +50,000 | $7.50 | 03/28/2024 | 03/18/2026 |
| Abelis Bar Berta | OTHER | +20,000 | $7.50 | 03/28/2024 | 03/18/2026 |
| Havron Avraham | OTHER | +24,000 | $6.39 | 05/02/2023 | 03/18/2026 |